SCHEMBL22848870

SCHEMBL22848870

COc1cc2nn(C3CCCCC3)cc2cc1NC(=O)c1c(F)cccc1F

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 20/20 0.60
FLT3 P36888 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22848796 0.91 IRAK4 (0.59) IRAK4
SCHEMBL22849148 0.90 IRAK4 (0.58) IRAK4FLT3
SCHEMBL26349196 0.89 IRAK4 (0.58) IRAK4
SCHEMBL22848856 0.86 IRAK4 (0.55) IRAK4FLT3
SCHEMBL22848523 0.85 IRAK4 (0.59) IRAK4FLT3
SCHEMBL22848859 0.85 IRAK4 (0.55) IRAK4FLT3
SCHEMBL22849016 0.84 IRAK4 (0.60) IRAK4FLT3
SCHEMBL22848626 0.84 IRAK4 (0.68) IRAK4FLT3
SCHEMBL22849190 0.83 IRAK4 (0.57) IRAK4FLT3
SCHEMBL22848564 0.83 IRAK4 (0.59) IRAK4FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed